logo

United Therapeutics Corp (UTHR)



Trade UTHR now with
  Date
  Headline
5/24/2022 6:06:23 AM United Therapeutics: FDA Approves Tyvaso DPI For Pulmonary Arterial Hypertension And PH-ILD
5/4/2022 6:09:17 AM United Therapeutics Q1 Total Revenue Rises 22% Year-over-year To $461.9 Mln
4/6/2022 6:06:27 AM Evelo Biosciences Names Jose-Carlos Gutiérrez-Ramos And Tonya Williams To Board
4/6/2022 6:05:28 AM United Therapeutics Publishes Tyvaso DPI BREEZE Clinical and Long-term Data In The Journal Pulmonary Circulation
2/24/2022 6:10:37 AM United Therapeutics Q4 EPS $2.35 Vs. $2.19 Last Year
11/3/2021 6:02:13 AM United Therapeutics Q3 EPS $3.42 Vs. $3.84 Last Year
9/7/2021 6:02:47 AM United Therapeutics Presents Tyvaso DPI BREEZE Clinical Data At European Respiratory Society International Congress 2021
8/25/2021 6:07:39 AM United Therapeutics, Former NFL Player Devon Still, Daughter Leah To Launch "Braving NeuroBLASToma"
8/24/2021 6:05:06 AM United Therapeutics To Present Tyvaso DPI™ BREEZE Clinical Data At ERS International Congress 2021
8/4/2021 6:04:45 AM United Therapeutics Q2 EPS $3.65 Vs. $2.41 Last Year
6/16/2021 11:02:35 AM MannKind : FDA Accepts For Priority Review Of NDA For Tyvaso DPI For Treatment Of PAH And PH-ILD
6/7/2021 6:02:22 AM United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia
6/3/2021 6:04:22 AM United Therapeutics Enrolls First Patient In Phase 3 TETON Study Of Tyvaso In Idiopathic Pulmonary Fibrosis
5/5/2021 6:24:13 AM United Therapeutics Q1 EPS $0.63; Non-GAP EPS $3.49
4/19/2021 6:08:32 AM MannKind, United Therapeutics Reach Milestone In Development Of Tyvaso DPI